Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 225 recruiting now early-phase tilt #2 of 28,963 conditions

Healthy: early-phase trial registry

225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2 of 28,963 conditions by registered trial count.

1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count

Healthy: 1,096 US clinical trials tracked, 225 recruiting.

Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.

Open enrollment, early-phase tilt

Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.

225
recruiting participants now
21%
of trials open to enrollment
43
in Phase 3-4 (later-stage)
55
top sponsor: Eli Lilly and Company

Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy is recruiting below its size-band peers.

    225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy trials is spread across many organizations.

    Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.

  4. Healthy research is mostly interventional.

    905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1518Phase 228Phase 311Phase 432

Open and recent trials

1,096 total, page 15 of 22

COMPLETED NA 36 participants

Bioequivalence Study of Zolpidem 10mg Tablets Under Fasting Conditions

Ranbaxy Laboratories Limited

NCT00779051

COMPLETED Phase 1 36 participants

Azithromycin 600 Mg Tablets, Fasting

Teva Pharmaceuticals U

NCT00834756

COMPLETED Phase 1 36 participants

Food Effect Study of AG120 in Healthy Subjects

Agios Pharmaceuticals

NCT02579707

COMPLETED Phase 1 36 participants

Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease

Bristol-Myers Squibb

NCT00901498

COMPLETED Phase 1 36 participants

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00083330

COMPLETED Phase 1 36 participants

Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

Ono Pharma USA

NCT01489345

COMPLETED Phase 1 36 participants

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

Teva Pharmaceuticals U

NCT00838630

COMPLETED Phase 1 36 participants

Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

Mylan Pharmaceuticals

NCT00648219

COMPLETED 36 participants

Alarms Due to Loss of Signal Integrity in Partially Wireless Versus Traditional Pulse Oximetry in Pediatric Patients

Pamela Petersen

NCT03187665

COMPLETED Phase 1 36 participants

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

Teva Pharmaceuticals U

NCT00830024

COMPLETED Phase 1 36 participants

Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg

Mylan Pharmaceuticals

NCT00649623

COMPLETED Phase 1 35 participants

A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants

Eli Lilly and Company

NCT06111521

COMPLETED NA 35 participants

Efficacy of Pea Hull Fibre Supplementation

University of Florida

NCT02778230

COMPLETED Phase 4 35 participants

The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals

Dost Ongur

NCT02536846

COMPLETED Phase 1 35 participants

Inorganic Nitrate: Sex Differences in Muscle Contractile Function and Efficiency

University of Virginia

NCT04588740

COMPLETED 35 participants

Mitochondrial Function in Circulating Cells and Muscle Tissue

University of Arkansas

NCT02700698

COMPLETED Phase 1 35 participants

A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults

Pfizer

NCT06466473

COMPLETED 34 participants

Oxygen Reserve Index Validation for RD Lite Sensors

Masimo Corporation

NCT03128892

COMPLETED NA 34 participants

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

Ranbaxy Laboratories Limited

NCT00777972

COMPLETED Phase 1 34 participants

Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers

Pain Therapeutics

NCT02117583

COMPLETED NA 34 participants

MiCrobiome dieT Study

University of Minnesota

NCT03610477

COMPLETED NA 34 participants

Effect of Late Dinner on Nocturnal Metabolism

Johns Hopkins University

NCT03525717

COMPLETED NA 34 participants

Black Walnuts and Health

University of Georgia

NCT04849949

COMPLETED Phase 1 34 participants

Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects

Pfizer

NCT01103726

COMPLETED 34 participants

Right Ventricular Metabolism in Pulmonary Arterial Hypertension

Vanderbilt University Medical Center

NCT02763735

COMPLETED NA 34 participants

Measurement of Glucose Metabolism in Humans: Effect of Recurrent Hypoglycemia on Hypothalamic GABA

University of Minnesota

NCT02829593

COMPLETED Phase 1 33 participants

A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

Rockefeller University

NCT02511990

COMPLETED Phase 1 33 participants

Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers

Janssen Research & Development

NCT01690286

COMPLETED Phase 1 33 participants

A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants

Eli Lilly and Company

NCT05440136

COMPLETED Phase 1 33 participants

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Teva Pharmaceuticals U

NCT01182207

COMPLETED NA 33 participants

Wearable Devices to Monitor Seizures in Autoimmune Epilepsy

Mayo Clinic

NCT05627661

COMPLETED NA 32 participants

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

Ranbaxy Laboratories Limited

NCT00775996

COMPLETED Phase 1 32 participants

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)

Javelin Pharmaceuticals

NCT00474799

COMPLETED Phase 1 32 participants

A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants

Eli Lilly and Company

NCT05630274

COMPLETED Phase 1 32 participants

Safety, Tolerability and Pharmacokinetics of BIIB118 (PF-05251749)

Biogen

NCT02443740

COMPLETED Phase 1 32 participants

To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants

Janssen Research & Development

NCT01809353

COMPLETED Phase 1 32 participants

A Study of LY3871801 in Healthy Asian and Non-Asian Participants

Eli Lilly and Company

NCT05960851

COMPLETED Phase 1 32 participants

A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers

AstraZeneca

NCT00726427

COMPLETED Phase 1 32 participants

Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects

Bristol-Myers Squibb

NCT01471717

COMPLETED NA 32 participants

Relative Efficacy of Vitamins D2 and D3 in Adult Humans

Creighton University

NCT01139840

COMPLETED Phase 1 32 participants

Pharmacokinetics of Telavancin in Normal and Obese Subjects

University of Illinois at Chicago

NCT02753855

COMPLETED 32 participants

An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions

Medical University of South Carolina

NCT00200798

COMPLETED Phase 1 32 participants

HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00102089

COMPLETED Phase 1 32 participants

Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.

Novartis

NCT00417196

COMPLETED Phase 1 32 participants

A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

Exelixis

NCT01761773

COMPLETED Phase 1 32 participants

The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects

Staidson Biopharma

NCT05085197

COMPLETED NA 32 participants

Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions

Ranbaxy Laboratories Limited

NCT00775177

COMPLETED NA 32 participants

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

Ranbaxy Laboratories Limited

NCT00778427

COMPLETED Phase 1 32 participants

A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.

Pfizer

NCT00832052

COMPLETED Phase 1 32 participants

Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

Inovio Pharmaceuticals

NCT01142362

← Previous Page 15 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 518
Phase 2 28
Phase 3 11
Phase 4 32

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Healthy right now

225 recruiting of 1,096 indexed (21% open).

Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).

Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 50 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Healthy?

PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Healthy?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.